November 29, 2020

Vaccine giant to apply for pandemic licence in ‘two weeks’

[ad_1]

Credit: Pixabay/CC0 Public Domain

The world’s largest vaccine manufacturer by volume said Saturday it would apply for an emergency licence for a coronavirus vaccine within two weeks, and that confusion over the efficacy would not delay its distribution.

Serum Institute of India chief executive Adar Ponnawala also confirmed that the Pune-based giant would be able to produce at least 100 million doses a month from early 2021 of Covishield, which was developed by Astrazeneca and Oxford University.

Poonawalla spoke after a visit to the plant by Prime Minister Narendra Modi, whose government wants 300-400 million doses by July next